BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35429904)

  • 1. AKR1C1 promotes non-small cell lung cancer proliferation via crosstalk between HIF-1α and metabolic reprogramming.
    Chang LL; Lu PH; Yang W; Hu Y; Zheng L; Zhao Q; Lin NM; Zhang WZ
    Transl Oncol; 2022 Jun; 20():101421. PubMed ID: 35429904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.
    Zhu H; Chang LL; Yan FJ; Hu Y; Zeng CM; Zhou TY; Yuan T; Ying MD; Cao J; He QJ; Yang B
    Theranostics; 2018; 8(3):676-692. PubMed ID: 29344298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer.
    Fu Z; Li S; Liu J; Zhang C; Jian C; Wang L; Zhang Y; Shi C
    Front Pharmacol; 2022; 13():847906. PubMed ID: 35370661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer.
    Huang Y; Chen Z; Lu T; Bi G; Li M; Liang J; Hu Z; Zheng Y; Yin J; Xi J; Lin Z; Zhan C; Jiang W; Wang Q; Tan L
    J Exp Clin Cancer Res; 2021 Dec; 40(1):398. PubMed ID: 34930376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKR1C1 connects autophagy and oxidative stress by interacting with SQSTM1 in a catalytic-independent manner.
    Chang LL; Li YK; Zhao CX; Zeng CM; Ge FJ; Du JM; Zhang WZ; Lu PH; He QJ; Zhu H; Yang B
    Acta Pharmacol Sin; 2022 Mar; 43(3):703-711. PubMed ID: 34017066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA circPIP5K1A promotes non-small cell lung cancer proliferation and metastasis through miR-600/HIF-1α regulation.
    Chi Y; Luo Q; Song Y; Yang F; Wang Y; Jin M; Zhang D
    J Cell Biochem; 2019 Nov; 120(11):19019-19030. PubMed ID: 31241217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced ALDH3A1 promotes the proliferation of non-small-cell lung cancer by regulating energy metabolism reprogramming.
    Chen Y; Yan H; Yan L; Wang X; Che X; Hou K; Yang Y; Li X; Li Y; Zhang Y; Hu X
    Cell Death Dis; 2023 Sep; 14(9):617. PubMed ID: 37730658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKR1C1 Contributes to Cervical Cancer Progression via Regulating TWIST1 Expression.
    Wei X; Wei Z; Li Y; Tan Z; Lin C
    Biochem Genet; 2021 Apr; 59(2):516-530. PubMed ID: 33170398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
    Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
    Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
    [No Abstract]   [Full Text] [Related]  

  • 10. Ferroptosis-related gene AKR1C1 predicts the prognosis of non-small cell lung cancer.
    Huang F; Zheng Y; Li X; Luo H; Luo L
    Cancer Cell Int; 2021 Oct; 21(1):567. PubMed ID: 34702254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-sensitive long noncoding RNA CASC15 promotes lung tumorigenesis by regulating the SOX4/β-catenin axis.
    Sun J; Xiong Y; Jiang K; Xin B; Jiang T; Wei R; Zou Y; Tan H; Jiang T; Yang A; Jia L; Wang L
    J Exp Clin Cancer Res; 2021 Jan; 40(1):12. PubMed ID: 33407675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung Cancer.
    Zhu H; Hu Y; Zeng C; Chang L; Ge F; Wang W; Yan F; Zhao Q; Cao J; Ying M; Gu Y; Zheng L; He Q; Yang B
    Theranostics; 2020; 10(5):2188-2200. PubMed ID: 32104503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of miR-199a on rats with non-small cell lung cancer via regulating the HIF-1α/VEGF signaling pathway.
    Wang LM; Zhang LL; Wang LW; Zhu L; Ma XX
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10363-10369. PubMed ID: 31841190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
    Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
    Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
    [No Abstract]   [Full Text] [Related]  

  • 15. Co-expression of PD-L1 and HIF-1α predicts poor prognosis in Patients with Non-small Cell Lung Cancer after surgery.
    Zheng H; Ning Y; Zhan Y; Liu S; Yang Y; Wen Q; Fan S
    J Cancer; 2021; 12(7):2065-2072. PubMed ID: 33754005
    [No Abstract]   [Full Text] [Related]  

  • 16. miR-224 aggravates cancer-associated fibroblast-induced progression of non-small cell lung cancer by modulating a positive loop of the SIRT3/AMPK/mTOR/HIF-1α axis.
    Zhang J; Han L; Yu J; Li H; Li Q
    Aging (Albany NY); 2021 Apr; 13(7):10431-10449. PubMed ID: 33819917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midkine Is a Potential Therapeutic Target of Tumorigenesis, Angiogenesis, and Metastasis in Non-Small Cell Lung Cancer.
    Shin DH; Jo JY; Kim SH; Choi M; Han C; Choi BK; Kim SS
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer.
    Zhou C; Ye L; Jiang C; Bai J; Chi Y; Zhang H
    Tumour Biol; 2015 Dec; 36(12):9179-88. PubMed ID: 26088446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α.
    Faubert B; Vincent EE; Griss T; Samborska B; Izreig S; Svensson RU; Mamer OA; Avizonis D; Shackelford DB; Shaw RJ; Jones RG
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2554-9. PubMed ID: 24550282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
    Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
    J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.